You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 30, 2025

Suppliers and packagers for VOLTAREN ARTHRITIS PAIN


✉ Email this page to a colleague

« Back to Dashboard


VOLTAREN ARTHRITIS PAIN

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Haleon Us Holdings VOLTAREN ARTHRITIS PAIN diclofenac sodium GEL;TOPICAL 022122 NDA Haleon US Holdings LLC 0067-8152-01 1 TUBE in 1 CARTON (0067-8152-01) / 20 g in 1 TUBE 2020-05-13
Haleon Us Holdings VOLTAREN ARTHRITIS PAIN diclofenac sodium GEL;TOPICAL 022122 NDA Haleon US Holdings LLC 0067-8152-02 1 TUBE in 1 CARTON (0067-8152-02) / 50 g in 1 TUBE 2020-05-13
Haleon Us Holdings VOLTAREN ARTHRITIS PAIN diclofenac sodium GEL;TOPICAL 022122 NDA Haleon US Holdings LLC 0067-8152-03 1 TUBE in 1 CARTON (0067-8152-03) / 100 g in 1 TUBE 2020-05-13
Haleon Us Holdings VOLTAREN ARTHRITIS PAIN diclofenac sodium GEL;TOPICAL 022122 NDA Haleon US Holdings LLC 0067-8152-04 1 TUBE in 1 CARTON (0067-8152-04) / 150 g in 1 TUBE 2020-05-13
Haleon Us Holdings VOLTAREN ARTHRITIS PAIN diclofenac sodium GEL;TOPICAL 022122 NDA Haleon US Holdings LLC 0067-8152-08 2 TUBE in 1 CARTON (0067-8152-08) / 100 g in 1 TUBE 2020-05-13
Haleon Us Holdings VOLTAREN ARTHRITIS PAIN diclofenac sodium GEL;TOPICAL 022122 NDA Haleon US Holdings LLC 0067-8152-09 1 TUBE in 1 CARTON (0067-8152-09) / 20 g in 1 TUBE 2020-05-13
Haleon Us Holdings VOLTAREN ARTHRITIS PAIN diclofenac sodium GEL;TOPICAL 022122 NDA Haleon US Holdings LLC 0067-8153-01 1 KIT in 1 CARTON (0067-8153-01) * 2 TUBE in 1 KIT / 150 g in 1 TUBE * 1 TUBE in 1 KIT / 50 g in 1 TUBE 2020-05-13
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Voltaren Arthritis Pain

Last updated: July 28, 2025

Introduction

Voltaren Arthritis Pain, a topical formulation containing diclofenac, is a widely used nonsteroidal anti-inflammatory drug (NSAID) for managing osteoarthritis and arthritis-related discomfort. Its global demand underscores the importance of a reliable and comprehensive supplier network. This article provides a detailed overview of key suppliers across manufacturing, active pharmaceutical ingredient (API) sourcing, packaging, and distribution channels, offering critical insights for stakeholders involved in procurement, regulatory compliance, and strategic planning.


Manufacturers of Voltaren Arthritis Pain

Major pharmaceutical companies manufacture Voltaren Arthritis Pain, with Novartis being the primary developer and marketer of the brand. Novartis, with a robust manufacturing infrastructure, collaborates with regional and contract manufacturers globally to meet the demand.

Novartis has established manufacturing facilities across North America, Europe, and Asia, ensuring supply continuity and compliance with Good Manufacturing Practices (GMP). The company often partners with Contract Manufacturing Organizations (CMOs) to scale production and manage regional distribution.

Additionally, other pharmaceutical producers sometimes offer generic formulations of diclofenac topical gels, although these are marketed under different brand names and are not identical to Voltaren. Procurement of Voltaren-branded products typically requires engaging authorized distributors or directly working with Novartis or its licensed regional partners.


Active Pharmaceutical Ingredient (API) Suppliers

Diclofenac sodium, the active ingredient in Voltaren Arthritis Pain, is supplied by several global API manufacturers. Reliable API sourcing is critical since the quality, purity, and consistency directly impact product efficacy and regulatory compliance.

Key API Suppliers:

  • Novartis: Beyond manufacturing the final product, Novartis sources diclofenac sodium from specialized API producers (often in India, China, or Europe) to meet volume requirements and quality standards.

  • Hetero Drugs Ltd. (India): A prominent API manufacturer supplying diclofenac sodium compliant with international regulatory standards, including USP and EP specifications.

  • BASF (Germany): Known for high-quality pharmaceutical intermediates, BASF produces diclofenac sodium with strict adherence to GMP regulations.

  • Jubilant Life Sciences (India): Offers API manufacturing services, including diclofenac sodium, with a focus on global exports and regulatory compliance.

  • Viatris: An established global API supplier sourcing from multiple regions to ensure supply chain flexibility and quality governance.

The API supply chain is often characterized by multi-source procurement, ensuring no single supplier disruption affects the final product availability.


Formulation and Packaging Suppliers

The topical gel formulation of Voltaren Arthritis Pain requires specialized excipients, such as gelling agents, stabilizers, and preservatives. Large pharmaceutical formulators typically maintain vertical integration or partnerships for formulation development and packaging.

Packaging Suppliers:

  • Gerresheimer: Supplies high-quality Pharma-grade glass and plastic containers used for topical gels.

  • Bormioli Rocco: Provides bottles and tubes that meet pharmaceutical regulatory standards for topical medication packaging.

  • Schott AG: Offers premium aluminum tubes and syringes suited for topical NSAIDs.

  • Albéa: Specializes in cosmetic and pharmaceutical packaging, including pump systems, applicators, and tubing.

Kitting and serialization—fundamental for anti-counterfeiting—are handled by specialized extrusion and labeling companies, often integrated into the supply chain by Novartis or authorized distributors.


Distribution and Regional Suppliers

Global distribution hinges on regional warehouses, authorized distributors, and local pharmacies.

Distribution Channels:

  • Novartis Distribution Network: Novartis operates extensive distribution centers primarily in North America, Europe, Asia-Pacific, and Latin America, ensuring regulatory compliance and logistics efficiency.

  • Independent Distributors: Authorized regional distributors, such as Alliance Healthcare (Europe), McKesson, and AmerisourceBergen (North America), facilitate the movement of Voltaren products to retail pharmacies, hospitals, and clinics.

  • Online Pharmacies and Logistics Providers: E-commerce platforms and third-party logistics providers have expanded reach, especially in regions with streamlined distribution channels, such as the US and parts of Europe.


Supply Chain Security and Regulatory Considerations

Supply chain integrity remains essential to prevent counterfeit or substandard Voltaren products. The involvement of certified suppliers with GMP accreditation and serialization capabilities is paramount. Procurement professionals should verify supplier accreditation via databases maintained by the FDA, EMA, and other regulatory authorities.

Regulatory compliance also extends to quality audits, supplier qualification, and adverse event reporting, reinforcing the importance of selecting suppliers with proven adherence to international standards.


Emerging Trends in Voltaren Supply Chain

  • Shift to Regional API Production: To mitigate global supply disruptions, companies are increasingly sourcing API locally or regionally, especially following COVID-19-related bottlenecks.

  • Increased Use of Contract Manufacturing Organizations (CMOs): Outsourcing formulation and packaging reduces costs and increases flexibility amid fluctuating demand.

  • Enhanced Supply Chain Resilience: Companies are diversifying suppliers and incorporating digital tracking to ensure supply continuity.


Key Suppliers Summary

Category Prominent Companies Notes
Brand Manufacturer Novartis (Global) Main producer and marketer of Voltaren Arthritis Pain
API Suppliers Jubilant Life Sciences, Hetero Drugs, BASF, Vitrus Multi-region sourcing ensures supply security
Formulation & Packaging Gerresheimer, Albéa, Bormioli Rocco Specialized packaging for topical gels
Distribution & Logistics Novartis Distribution, McKesson, Alliance Healthcare Regional-distributor networks facilitate access

Key Takeaways

  • Primary Manufacturer: Novartis leads in Voltaren Arthritis Pain production, with collaboration across regional CMOs.

  • API Sourcing: Reliable diclofenac sodium suppliers include Jubilant, Hetero, BASF, and Vitrus, ensuring regulatory compliance and supply stability.

  • Packaging & Formulation: Top-tier packaging suppliers such as Gerresheimer and Albéa provide essential components, with quality controls integral to product integrity.

  • Supply Chain Resilience: Diversification of suppliers and regional manufacturing plays a vital role in mitigating disruptions.

  • Regulatory Oversight: Maintaining compliance with GMP, serialization, and quality standards is critical for procurement and distribution.


FAQs

1. How can I verify the authenticity of Voltaren Arthritis Pain products from suppliers?
Verify suppliers' GMP certifications and serializations, and procure exclusively through authorized distributors and approved channels to ensure product authenticity.

2. Are generic versions of Voltaren Arthritis Pain manufactured by the same suppliers?
Generic formulations may be produced by different manufacturers, often using different APIs, but must meet equivalent efficacy and safety standards, with supply chain verification necessary for authenticity.

3. What are the risks associated with API supply chain disruptions for Voltaren?
Disruptions can lead to shortages, quality variability, and regulatory compliance issues. Diversification of API sources mitigates these risks.

4. How does regional manufacturing impact the availability of Voltaren products?
Regional manufacturing enhances supply resilience, reduces lead times, and complies with regional regulations, but may introduce variability in supplier quality and regulation standards.

5. What role do packaging suppliers play in preventing counterfeit Voltaren products?
Advanced packaging suppliers incorporate serialization, tamper-evident features, and anti-counterfeiting measures like holograms and QR codes, safeguarding product integrity.


Sources:

  1. Novartis Official Website. https://www.novartis.com
  2. API Manufacturers' Data Sheets. (Various, including Jubilant Life Sciences and BASF)
  3. European Medicines Agency (EMA). Good Manufacturing Practice Guide.
  4. Global Pharmaceutical Packaging Standards. (Schott, Albéa, Gerresheimer)
  5. Regulatory Authorities’ Databases (FDA, EMA).

End of Article

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.